Livforsakringsbolaget Skandia’s Organon & Co OGN Stock Holding History

Livforsakringsbolaget Skandia’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12,542	Closed	-$293K	–	593
2022 Q3	$293K	Hold	12,542	–	–	0.04%	228
2022 Q2	$423K	Hold	12,542	–	–	0.04%	251
2022 Q1	$438K	Hold	12,542	–	–	0.03%	291
2021 Q4	$382K	Sell	12,542 -16,666	-57%	-$543K	0.02%	321
2021 Q3	$916K	Buy	29,208 +12,542	+75%	+$401K	0.06%	245
2021 Q2	$505K	Buy	+16,666	New	+$549K	0.03%	346

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Livforsakringsbolaget Skandia's OGN Position: Q4 2022 in Review

Livforsakringsbolaget Skandia sold out of Organon & Co (OGN) in Q4 2022, closing a stake of 12,542 shares — an estimated $293K sold.

Livforsakringsbolaget Skandia first reported a position in OGN in Q2 2021 and held it in 6 quarters. The position peaked at $916K in Q3 2021. 823 funds tracked by Wall St. Rank hold OGN as of Q4 2022.

Livforsakringsbolaget Skandia reported no remaining Organon & Co position as of Q4 2022 after selling out during the quarter.
Livforsakringsbolaget Skandia sold 12,542 Organon & Co shares in Q4 2022, an estimated $293K.
Livforsakringsbolaget Skandia first reported a position in Organon & Co in Q2 2021 and held it in 6 quarters.
Livforsakringsbolaget Skandia's Organon & Co position peaked at $916K in Q3 2021.
823 funds tracked by Wall St. Rank held Organon & Co as of Q4 2022.

Based on Livforsakringsbolaget Skandia's 13F filing for Q4 2022, filed 13 Feb 2023.